ArticleCancers2019

Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice.

Wan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.